Catalyst Wire Dossier Catalyst Wire Dossier

ZARONTIN

ethosuximide · Parke-Davis Div of Pfizer Inc
Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for ZARONTIN, covering 2006-09-01 to 2021-10-29. Get the full timeline:

Most recent: FDA Approved: ZARONTIN — Supplemental Application (Parke-Davis Div of Pfizer Inc)

See pricing